208 related articles for article (PubMed ID: 18534217)
21. Hyperbilirubinemia screening and treatment in neonates born prior to 35 weeks of gestation.
Khan S; Coo H; Khurshid F
J Neonatal Perinatal Med; 2024; 17(2):177-182. PubMed ID: 38427505
[TBL] [Abstract][Full Text] [Related]
22. Clinical predictive score of predischarge screening for severe hyperbilirubinemia in late preterm and term infants.
Thanomsingh P
Pediatr Neonatol; 2020 Aug; 61(4):378-384. PubMed ID: 32156481
[TBL] [Abstract][Full Text] [Related]
23. Use of Transcutaneous Bilirubin to Determine the Need for Phototherapy in Resource-Limited Settings.
Olusanya BO; Emokpae AA
Neonatology; 2017; 111(4):324-330. PubMed ID: 28073104
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors and Predictors of Rebound Hyperbilirubinemia in a Term and Late-Preterm Infant with Hemolysis.
Almohammadi H; Nasef N; Al-Harbi A; Saidy K; Nour I
Am J Perinatol; 2022 Jun; 39(8):836-843. PubMed ID: 33231268
[TBL] [Abstract][Full Text] [Related]
25. Risk Factors Predicting the Need for Phototherapy in Glucose 6 Phosphate Dehydrogenase-Deficient Infants in a Large Retrospective Cohort Study.
Gopagondanahalli KR; Mittal RA; Abdul Haium AA; Quek BH; Agarwal P; Daniel LM; Chua MC; Rajadurai VS
Neonatology; 2022; 119(4):494-500. PubMed ID: 35700699
[TBL] [Abstract][Full Text] [Related]
26. Pre-phototherapy total serum bilirubin levels in extremely preterm infants.
Jegathesan T; Ray JG; Keown-Stoneman CDG; Campbell DM; Shah V; Berger H; Hayeems RZ; Sgro M;
Pediatr Res; 2023 Jan; 93(1):226-232. PubMed ID: 35523883
[TBL] [Abstract][Full Text] [Related]
27. Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines.
Newman TB; Kuzniewicz MW; Liljestrand P; Wi S; McCulloch C; Escobar GJ
Pediatrics; 2009 May; 123(5):1352-9. PubMed ID: 19403502
[TBL] [Abstract][Full Text] [Related]
28. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization.
Newman TB; Liljestrand P; Escobar GJ
Pediatrics; 2003 Jun; 111(6 Pt 1):1303-11. PubMed ID: 12777545
[TBL] [Abstract][Full Text] [Related]
29. [Uniform intervention criteria for jaundice in hyperbilirubinemia in preterm infants].
van Imhoff DE; Dijk PH; Hulzebos CV;
Ned Tijdschr Geneeskd; 2009; 153():A94. PubMed ID: 19785878
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of phototherapy for newborns with hyperbilirubinemia: a cautionary example of an instrumental variable analysis.
Newman TB; Vittinghoff E; McCulloch CE
Med Decis Making; 2012; 32(1):83-92. PubMed ID: 21859678
[TBL] [Abstract][Full Text] [Related]
31. Unbound bilirubin measurements in term and late-preterm infants.
Hegyi T; Chefitz D; Weller A; Huber A; Carayannopoulos M; Kleinfeld A
J Matern Fetal Neonatal Med; 2022 Apr; 35(8):1532-1538. PubMed ID: 32366186
[TBL] [Abstract][Full Text] [Related]
32. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.
Newman TB; Liljestrand P; Jeremy RJ; Ferriero DM; Wu YW; Hudes ES; Escobar GJ;
N Engl J Med; 2006 May; 354(18):1889-900. PubMed ID: 16672700
[TBL] [Abstract][Full Text] [Related]
33. Randomized controlled trial of light-emitting diode phototherapy.
Maisels MJ; Kring EA; DeRidder J
J Perinatol; 2007 Sep; 27(9):565-7. PubMed ID: 17597827
[TBL] [Abstract][Full Text] [Related]
34. Effect of universal neonatal transcutaneous bilirubin screening on blood draws for bilirubin analysis and phototherapy usage.
Wickremasinghe AC; Karon BS; Saenger AK; Cook WJ
J Perinatol; 2012 Nov; 32(11):851-5. PubMed ID: 22343396
[TBL] [Abstract][Full Text] [Related]
35. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns.
Newman TB; Liljestrand P; Escobar GJ
Arch Pediatr Adolesc Med; 2005 Feb; 159(2):113-9. PubMed ID: 15699303
[TBL] [Abstract][Full Text] [Related]
36. Problems with using total serum bilirubin as a criterion for phototherapy in extremely low-birthweight infants.
Ichinomiya K; Inoue F; Koizumi A; Inoue T; Fujiu T; Maruyama K
Pediatr Int; 2014 Oct; 56(5):731-4. PubMed ID: 24689889
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Transcutaneous and Serum Bilirubin Measurements in Neonates 30 to 34 Weeks' Gestation Before, During, and After Phototherapy.
Jnah A; Newberry DM; Eisenbeisz E
Adv Neonatal Care; 2018 Apr; 18(2):144-153. PubMed ID: 29498944
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of oral agar in management of indirect hyperbilirubinemia in full-term neonates.
Abdel-Aziz Ali SM; Mansour Galal S; Sror SM; Hussein O; Abd-El-Haseeb Ahmed AO; Hamed EA
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):975-980. PubMed ID: 32192396
[TBL] [Abstract][Full Text] [Related]
39. Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial.
Sachdeva M; Murki S; Oleti TP; Kandraju H
Eur J Pediatr; 2015 Feb; 174(2):177-81. PubMed ID: 25005717
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for maternal-fetal blood group incompatibility and hemolytic disease of the newborn.
Calkins K; Roy D; Molchan L; Bradley L; Grogan T; Elashoff D; Walker V
J Neonatal Perinatal Med; 2015; 8(3):243-50. PubMed ID: 26518407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
